Glucagen-Like Peptides

Author reply to: Exploring the impact of short-acting GLP-1 receptor agonists on GERD risk
Benjamin Douglas Liu, Gengqing Song

Gut Feb 2024, gutjnl-2024-332058; DOI: 10.1136/gutjnl-2024-332058
GORD and GLP-1 receptor agonists: an emerging concern for gastroenterologists
Benson T Massey

Gut Feb 2024, 73 (2) 211-212; DOI: 10.1136/gutjnl-2023-331027
Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort study
Benjamin Douglas Liu, Sharon C Udemba, Katherine Liang, Yasir Tarabichi, Hannah Hill, Ronnie Fass, Gengqing Song

Gut Feb 2024, 73 (2) 246-254; DOI: 10.1136/gutjnl-2023-329651
Antiobesity interventions: options, evidence and value
Elena B Elkin, Chin Hur

Gut Nov 2023, gutjnl-2023-330768; DOI: 10.1136/gutjnl-2023-330768
Author reply to: Increased Incidence of GERD in GLP-1 treated patients – fact or artefact?
Benjamin Douglas Liu, Gengqing Song

Gut Nov 2023, gutjnl-2023-331411; DOI: 10.1136/gutjnl-2023-331411
6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice
Kassem Makki, Harald Brolin, Natalia Petersen, Marcus Henricsson, Dan Ploug Christensen, Muhammad Tanweer Khan, Annika Wahlström, Per-Olof Bergh, Valentina Tremaroli, Kristina Schoonjans, Hanns-Ulrich Marschall, Fredrik Bäckhed

Gut Feb 2023, 72 (2) 314-324; DOI: 10.1136/gutjnl-2021-326541
Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet
Ville Wallenius, Erik Elias, Erik Elebring, Bauke Haisma, Anna Casselbrant, Pierre Larraufie, Emma Spak, Frank Reimann, Carel W le Roux, Neil G Docherty, Fiona M Gribble, Lars Fändriks

Gut Aug 2020, 69 (8) 1423-1431; DOI: 10.1136/gutjnl-2019-319372
Manipulation of the gut–liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?
Daniel Jahn, Marco Marzioni, Andreas Geier

Gut Sep 2018, 67 (9) 1565-1567; DOI: 10.1136/gutjnl-2018-316375
GLP-1 based therapies: clinical implications for gastroenterologists
Mark M Smits, Daniel H van Raalte, Lennart Tonneijck, Marcel H A Muskiet, Mark H H Kramer, Djuna L Cahen

Gut Apr 2016, 65 (4) 702-711; DOI: 10.1136/gutjnl-2015-310572
Paradoxical responses of plasma glucagon and bile acid levels after duodenal nutrient exclusion
Po-Chun Chen, Akio Inui, Chih-Yen Chen

Gut Mar 2015, 64 (3) 516; DOI: 10.1136/gutjnl-2014-307607

Log in using your username and password

Main menu

Log in using your username and password

You are here

Glucagen-Like Peptides